Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).
about
Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo.Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.
P2860
Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Primary study in experimental ...... inoma with AGM-1470 (TNP-470).
@en
type
label
Primary study in experimental ...... inoma with AGM-1470 (TNP-470).
@en
prefLabel
Primary study in experimental ...... inoma with AGM-1470 (TNP-470).
@en
P2093
P1476
Primary study in experimental ...... inoma with AGM-1470 (TNP-470).
@en
P2093
P304
P577
1998-09-01T00:00:00Z